Browse Jaunts
Help
Social
Legal

Biologics and Biosimilars

Biologics and Biosimilars

@lucianapapaleo
@lucianapapaleo
7 Followers
1 month ago 172
Other

Biologics and Biosimilars

@lucianapapaleo1 month ago

About Biologics Biologics are a subset of a class of medications called disease-modifying antirhe…
1/2
Arthritis Fact Sheet Biologics & Biosimilars other drugs. A manufacturer must show that a biosimil…
2/2


  • ↑ Previous
  • ↓ Next
  • f Fullscreen
  • esc Exit Fullscreen
Related Jaunts
NextGen 2024: Refractory SJIA & MAS Session Part 2
NextGen 2024: Refractory SJIA & MAS Session Part 2
@SJIA_Foundation
2 weeks ago •  63 views
NextGen 2024: Weaning meds when disease is controlled Session Part 1
NextGen 2024: Weaning meds when disease is controlled Session Part 1
@SJIA_Foundation
2 weeks ago •  101 views
NextGen 2024: Weaning meds when disease is controlled Session Part 2
NextGen 2024: Weaning meds when disease is controlled Session Part 2
@SJIA_Foundation
2 weeks ago •  167 views
NextGen 2024: Refractory SJIA & MAS Session Part 5
NextGen 2024: Refractory SJIA & MAS Session Part 5
@SJIA_Foundation
2 weeks ago •  64 views
NextGen 2024: Refractory SJIA & MAS Session Part 8
NextGen 2024: Refractory SJIA & MAS Session Part 8
@SJIA_Foundation
2 weeks ago •  67 views
NextGen 2024: Refractory SJIA & MAS Session Part 1
NextGen 2024: Refractory SJIA & MAS Session Part 1
@SJIA_Foundation
2 weeks ago •  65 views
Clinical significance of serum IL-18 levels for the diagnosis and monitoring of disease activity
Clinical significance of serum IL-18 levels for the diagnosis and monitoring of disease activity
@SJIA_Foundation
2 weeks ago •  284 views
Biomarkers in Systemic Juvenile Idiopathic Arthritis, Macrophage Activation Syndrome and Their Importance in COVID Era
Biomarkers in Systemic Juvenile Idiopathic Arthritis, Macrophage Activation Syndrome and Their Importance in COVID Era
@rashmi
3 weeks ago •  128 views
NextGen 2024: Unmet Needs & Clinical Trial Challenges Session Part 1
NextGen 2024: Unmet Needs & Clinical Trial Challenges Session Part 1
@SJIA_Foundation
2 weeks ago •  72 views
NextGen 2024: Bone Marrow Transplantation (BMT) Session Part 5
NextGen 2024: Bone Marrow Transplantation (BMT) Session Part 5
@SJIA_Foundation
2 weeks ago •  70 views
NextGen 2024: Bone Marrow Transplantation (BMT) Session Part 3
NextGen 2024: Bone Marrow Transplantation (BMT) Session Part 3
@SJIA_Foundation
2 weeks ago •  79 views
IL-18 testing in the diagnosis and management of Still’s disease: Game-changer or Red Herring?
IL-18 testing in the diagnosis and management of Still’s disease: Game-changer or Red Herring?
@SJIA_Foundation
2 weeks ago •  81 views
Current treatments in macrophage activation syndrome - METAPHOR projec
Current treatments in macrophage activation syndrome - METAPHOR projec
@rashmi
2 months ago •  583 views
NextGen 2024: Unmet Needs & Clinical Trial Challenges Session Part 2
NextGen 2024: Unmet Needs & Clinical Trial Challenges Session Part 2
@SJIA_Foundation
2 weeks ago •  72 views
More from author
BMT in SJIA patients
BMT in SJIA patients
@lucianapapaleo
1 month ago •  135 views
Better Together
Better Together
@lucianapapaleo
1 month ago •  272 views
Caminhando com Confiança: Entendendo a Pesquisa Clinica
Caminhando com Confiança: Entendendo a Pesquisa Clinica
@lucianapapaleo
1 month ago •  94 views
@lucianapapaleo

Share

Biologics and Biosimilars

Embed code


Swipe LEFT
to view Related

Scroll DOWN
to read doc

This website uses cookies to improve your experience. By using this site, you consent to the use of cookies.

Login

OR

Forgot password?

Don't have an account? Sign Up